Advertisement
Advertisement

SNOA

SNOA logo

Sonoma Pharmaceuticals, Inc. Common Stock

1.29
USD
Sponsored
-0.15
-10.42%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

1.32

+0.03
+2.02%

Sonoma Pharmaceuticals, Inc. Common Stock Profile

About

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.

Info & Links

CEO

Amy Trombly

Headquarters

5445 CONESTOGA COURT, SUITE 150
BOULDER, CO 80301, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.sonomapharma.com

Auditor

Frazier & Deeter, LLC

Share holders

47

Employees

9

Sonoma Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.30M

Enterprise Value

1.10M

Enterprise Value/EBITDA(ttm)

-0.87

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.31

Price to Book(mrq)

2.23

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

38.80%

Operating Margin(ttm)

-4.13%

Profit Margin(ttm)

-10.99%

Return on Equity(ttm)

-26.32%

Return on Invested Capital(ttm)

-61.74%

Return on Assets(ttm)

-6.55%

Income Statement

Revenue(ttm)

21.92M

Revenue Per Share(ttm)

4.58

Gross Profit(ttm)

8.53M

EBITDA(ttm)3

-1.27M

Net Income Available to Common(ttm)

-2.26M

Diluted EPS(ttm)

-1.22

Share Statistics

Beta (5Y Monthly)

1.28

52-Week Change

-57.84%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

4.79M

Dividend Yield

0.00%

Float4

4.74M

% Held by Insiders

1.02%

% Held by Institutions

1.95%

Balance Sheet

Total Cash(mrq)

5.34M

Total Cash Per Share(mrq)

1.11

Total Debt(mrq)

140.00K

Total Debt/Equity(mrq)

2.12%

Current Ratio(mrq)

2.99%

Quick Ratio(mrq)

1.75%

Book Value Per Share(mrq)

1.38

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.17

Free Cash Flow(ytd)

-651.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement